Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Biochemical and Biophysical Research Communications
|
February 27, 2007
Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells
Johann Riedemann, Muhammad Sohail, Valentine M Macaulay
Biochemical and Biophysical Research Communications
|
February 20, 2007
The EGF receptor interacts with the type 1 IGF receptor and regulates its stability
Johann Riedemann, Megumi Takiguchi, Muhammad Sohail, et al.
Immunologic Research
|
May 30, 2024
Highlighting the role of CD44 in cervical cancer progression: immunotherapy's potential in inhibiting metastasis and chemoresistance
Cayleigh de Sousa, Carla Eksteen, Johann Riedemann, et al.
Nucleic Acids Research
|
March 26, 2003
A simple and cost-effective method for producing small interfering RNAs with high efficacy
Muhammad Sohail, Graeme Doran, Johann Riedemann, et al.
Cytokine & Growth Factor Reviews
|
December 5, 2025
Post COVID-19 pandemic Inflammatory Insights into Cancer: Consequences for immunotherapy
Carla Eksteen, Lé-Chandré Asja, Atarah Rass, et al.
Cancer Gene Therapy
|
October 23, 2004
Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer
Mark A Rochester, Johann Riedemann, Giles O Hellawell, et al.
Seminars in Oncology
|
June 12, 2025
Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy response
Carla Eksteen, Johann Riedemann, Frederick H van der Merwe, et al.
The Journal of Biological Chemistry
|
February 27, 2003
The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript
Erin A Bohula, Amanda J Salisbury, Muhammad Sohail, et al.
BMC Cell Biology
|
May 17, 2011
Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C
Gerrida M Uys, Amsha Ramburan, Benjamin Loos, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
June 17, 2024
A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer
Carla Eksteen, Johann Riedemann, Atarah M Rass, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Biochemical and Biophysical Research Communications
|
February 27, 2007
Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells
Johann Riedemann, Muhammad Sohail, Valentine M Macaulay
Biochemical and Biophysical Research Communications
|
February 20, 2007
The EGF receptor interacts with the type 1 IGF receptor and regulates its stability
Johann Riedemann, Megumi Takiguchi, Muhammad Sohail, et al.
Immunologic Research
|
May 30, 2024
Highlighting the role of CD44 in cervical cancer progression: immunotherapy's potential in inhibiting metastasis and chemoresistance
Cayleigh de Sousa, Carla Eksteen, Johann Riedemann, et al.
Nucleic Acids Research
|
March 26, 2003
A simple and cost-effective method for producing small interfering RNAs with high efficacy
Muhammad Sohail, Graeme Doran, Johann Riedemann, et al.
Cytokine & Growth Factor Reviews
|
December 5, 2025
Post COVID-19 pandemic Inflammatory Insights into Cancer: Consequences for immunotherapy
Carla Eksteen, Lé-Chandré Asja, Atarah Rass, et al.
Cancer Gene Therapy
|
October 23, 2004
Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer
Mark A Rochester, Johann Riedemann, Giles O Hellawell, et al.
Seminars in Oncology
|
June 12, 2025
Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy response
Carla Eksteen, Johann Riedemann, Frederick H van der Merwe, et al.
The Journal of Biological Chemistry
|
February 27, 2003
The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript
Erin A Bohula, Amanda J Salisbury, Muhammad Sohail, et al.
BMC Cell Biology
|
May 17, 2011
Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C
Gerrida M Uys, Amsha Ramburan, Benjamin Loos, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
June 17, 2024
A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer
Carla Eksteen, Johann Riedemann, Atarah M Rass, et al.
Page
of 2